From Gerald's Newsmax interview today, he said acr
Post# of 30027
(Total Views: 432)
Posted On: 01/15/2022 5:13:15 PM
.jpg)
From Gerald's Newsmax interview today, he said across the "several" clients Todos has (via Corona Diagnostics) they were probably doing 100k tests a day right now.
At this time last year, Meadowlands Diagnostics had only just set up and we still did $5-7M a month in sales off this when area Covid cases were 1/10th as high.
This is on top of the Provista Diagnostics testing and Tollovid sales. Q1 may revenue may end up extraordinarily high, I don't think it's crazy to record above $50M if you think about $10M a month from supplies, $7M a month from testing, and $1-2M in Tollovid and other. The math is hard to do, so that could be high, but, something to think about.
The run-up to Nasdaq could include Positive P2 data, great Q4 / Annual #'s (they likely will record $7M-12M in revenue Q4) and at the Q4 conference call they could project Q1 revenue.
I will be very interested to see what their burn is right now.
At this time last year, Meadowlands Diagnostics had only just set up and we still did $5-7M a month in sales off this when area Covid cases were 1/10th as high.
This is on top of the Provista Diagnostics testing and Tollovid sales. Q1 may revenue may end up extraordinarily high, I don't think it's crazy to record above $50M if you think about $10M a month from supplies, $7M a month from testing, and $1-2M in Tollovid and other. The math is hard to do, so that could be high, but, something to think about.
The run-up to Nasdaq could include Positive P2 data, great Q4 / Annual #'s (they likely will record $7M-12M in revenue Q4) and at the Q4 conference call they could project Q1 revenue.
I will be very interested to see what their burn is right now.
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼